首页> 外文期刊>RSC Advances >A biocompatible poly(amidoamine) (PAMAM) dendrimer octa-substituted with α-cyclodextrin towards the controlled release of doxorubicin hydrochloride from its ferrocenyl prodrug
【24h】

A biocompatible poly(amidoamine) (PAMAM) dendrimer octa-substituted with α-cyclodextrin towards the controlled release of doxorubicin hydrochloride from its ferrocenyl prodrug

机译:一种生物相容的聚(酰胺)(PAMAM)树枝状体Octa-取代α-环糊精朝向其盐酸二十甲素蛋白盐酸盐的控制释放

获取原文
           

摘要

Facile and efficient methods for the synthesis of the first poly(aminodamine) PAMAM G1.0 dendrimer octa-substituted with α-cyclodextrin and a novel ferrocenyl prodrug of doxorubicin hydrochloride are developed. This vector is non-toxic and can bind the designed ferrocenyl prodrug. It also shows a controlled drug release profile and high cytotoxicity against breast cancer cells (MCF-7), as elucidated by the in vitro biological studies performed with an innovative cell-on-a-chip microfluidic system.
机译:开发了适用于合成第一聚(氨基氨基胺)PAMAM G1.0 Dendrimer Octa-取代的具有α-环糊精和多柔枯辛素盐酸盐的新型二氧化钴素前药。该载体无毒,可以粘合设计的菲罗基苯基前药。它还显示了对乳腺癌细胞(MCF-7)的受控药物释放曲线和高细胞毒性,其通过具有创新的细胞对芯片微流体系统进行的体外生物学研究阐明。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号